875 E. Wisconsin Ave,Suite 800
Milwaukee , WI, 53202
Milwaukee , WI, 53202
Summary
The fund seeks maximum capital appreciation in the long term by investing in companies across any size outside the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
Next, the research team invests in US and non-US growth companies, including depositary receipts.
MoreLink
Directors
Dec 14, 2023- Coleen Downs Dinneen
- Gregory K. Ramirez
- Peter M. Lebovitz
- Peter E. Sundman
- Gail L. Hanson
- Bonnie L. Howard
- William J. Kelly
Chief Compliance Officer
- Jill M. Demski
Fund Manager(s)
- James Hamel
- Matthew Kamm
- Jason White
- Craigh Cepukenas
- Jay Warner
Price
- 52-Week High/Low
- $37.43 - $27
- Turnover
- 37.3%
- Expense Ratio
- 1.15%
Company Name |
Holding |
| Novo Nordisk A/S | 5.98 % |
| Boston Scientific Corp. | 5.21 % |
| BlackRock Liquidity Funds Treasury Trust Fund - Institutional Class | 4.32 % |
| Advanced Micro Devices, Inc. | 4.25 % |
| Netflix, Inc. | 3.95 % |
| Taiwan Semiconductor Manufacturing Co. Ltd. | 3.81 % |
| Intuit, Inc. | 3.4 % |
| Amazon.com, Inc. | 3.2 % |
| Microsoft Corp. | 3.14 % |
| London Stock Exchange Group plc | 3.05 % |
| More | 3.05 % |
Documents
Performance
YTD
-
3 Year
-6.05%
5 Year
-19.85%
Best
47.86%
2009
Worst
-30.38%
2022
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | - | 10.8% | 9.1% | -13.6% | -1.8% | -13.1% | 16.5% | 3.2% | 10.4% |
| Q2 | - | - | -3.8% | 5.7% | -20.6% | 20% | 27.7% | 4.7% | 2.4% | 8.2% |
| Q3 | - | - | - | -5.7% | -4.1% | -9.8% | 7.7% | -0.3% | 4.3% | 5.3% |
| Q4 | - | - | - | 11% | 5.8% | 4.6% | 0.9% | 1.9% | -16% | 4% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2025 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 0% | 10% | 20% | -30% | 3% | 31% | 0% | 0% | 0% |
Alpha
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| ARTRX | - | - | 10% | 20% | -30% | 3% | 31% | - | - | - |
| S&P 500 | - | - | - | - | -21% | 27% | 16% | 29% | -6% | 19% |
| Alpha | - | - | 10% | 20% | -9% | -24% | 14% | - | - | - |